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INTRODUCTION
Asthma and allergic rhinitis are chronic diseases with a steadi-
ly increasing prevalence. Worldwide, 300 million people suffer 
from asthma. In Germany alone, 7,000 people die because of 
asthma each year. The mortality rate is rising in most countries, 
and allergy and asthma have become public health problems 
throughout the world.1 
In principle, the allergic immune response results from a mis-
guided immune polarization against proteins and other harm-
less biomolecules. Allergic sensitization is complex and multi-
factorial, including a genetic predisposition to mount IgE re-
sponses (atopy), exposure to microbial diversity, allergens and 
environmental pollutants, and even use of antibiotics in infan-
cy.2,3 Moreover, protein-inherent features, such as protease ac-
tivity (Der p 1) or MD2 mimicry (Der p 2), contribute to the “al-
lergenicity” of certain molecules.4-6
HDM allergens are one of the main causes of allergy and asth-
ma, and increased exposure to indoor allergens has been sug-
gested as a possible reason for the general rise in allergic dis-
eases.7-10 The most frequent species are Dermatophagoides 
pteronyssinus (with the major allergens Der p 1 and Der p 2) 
and Dermatophagoides farinae (with the major allergens Der f 
1 and Der f 2). Both comprise mite “group 1” and “group 2” al-
lergens,11 and are common in European and American homes. 
Usually, HDMs colonize every part of a house, and HDM aller-
gens are chemically stable for many years.12,13 The structure and 
sequence of Der p 1 and Der f 1 are almost identical, thus re-
sulting in a high cross-reactivity and similar effects in patients.14
The concentration of HDM allergens correlates with clinical 
markers for asthma severity, e.g. peak expiratory flow (PEF) 
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variability, forced expiratory volume in 1 second (FEV1), or 
bronchial hyperresponsiveness (BHR) in asthmatic patients 
sensitized to HDMs.15 In general, the higher the allergen expo-
sure, the more patients have positive skin prick tests, but even 
exposure to lower levels of HDM allergens (20 ng/g) was found 
to be a significant risk factor for sensitization.16 Since early pub-
lications in the 1970s, allergologists have postulated decreased 
HDM load and HDM allergen concentration with increasing al-
titude and decreasing humidity,17-23 while some publications 
contradict this interpretation.24-27 Based on the assumption of a 
negative correlation of altitude and HDM concentration, aller-
gen avoidance therapies for HDM allergy and asthma are of-
fered in alpine regions. High-altitude climate therapy has been 
shown to positively affect medical parameters and symptoms 
of patients suffering from allergic airway diseases. Clinical stud-
ies verified that a stay at high altitude improves relevant surro-
gate parameters for allergy and asthma, such as the reduction 
in specific IgE levels, improved clinical asthma markers,28 or 
mitigate nonspecific BHR and epithelial shedding.15,29-33 
As a second major parameter, relative air humidity (RH, %) 
was postulated to significantly influence HDM growth, and low 
indoor RH was recommended to reduce HDM.22,33-35 However, 
in recent studies no association between HDM infestation and 
RH could be detected.36-38
Indoor allergens are usually attached to the surface of indoor 
particulate matter (PM), e.g. fine dust, which supports their 
transport to the respiratory tract and also acts as a bronchial ir-
ritant,39 which may also aggravate the allergenicity of indoor al-
lergens and was therefore measured in all buildings included in 
this study.40,41
The aim of the present study was to revisit the current hypoth-
esis that altitude inversely correlates with the HDM allergen 
concentration. For that purpose, HDM allergen concentrations 
were measured at different heights in alpine regions of Austria 
and Germany, and these data were analyzed in terms of fine 
dust pollution, temperature, humidity, and parameters of 
building characteristics and indoor environment.
MATERIALS AND METHODS
Collection of dust samples
A total of 122 dust samples (65 samples below and 57 samples 
above 1,500 m a.s.l.) were collected from different types of 
buildings, such as private residences, taverns, and mountain 
huts, located at altitudes between 400 m and 2,600 m a.s.l in al-
pine regions of Germany and Austria. All samples were taken 
during September in 2012 and 2014, which has been reported 
as the month with the highest concentrations of mites mea-
sured in house dust,19,42 using a DUSTREAMTM Collector with 
inserted nylon filter (INDOOR biotechnologiesINC, Charlottes-
ville, VA, USA) attached to a vacuum cleaner. According to the 
INDOOR biotechnologiesINC protocol, in all 4 corners of a room, 
as well as a mattress, an area of 21×30 cm was vacuumed for 
30 seconds. The samples collected were stored at -20°C in dust-
proof Ziploc bags (Toppits® Ziploc® Vaughan, ON, Canada).
Allergen quantification
Allergens were extracted by adding 2 mL of phosphate buff-
ered saline (PBS) to the dust samples, shaking (at RT/30 min), 
spinning (3 min/4,000 rpm) and using 50 µL of the supernatant 
for further measurement. Allergen concentrations were mea-
sured using a MARIA 5-plex Multiplex Array for Indoor Aller-
gens (MRA-C5) kit (INDOOR biotechnologiesINC) on a Luminex 
S-100 (Luminex, Austin, TX, USA) according to the manufac-
turers’ instructions. Concentrations of Der p 1, Der f 1, and aller-
gens of mite group 2 (both Der p 2 and Der f 2) were calculated 
via polynomial fit of raw fluorescent units into a dilution curve 
of allergen standards using xPONENT® software and expressed 
in ng/µL. The limit of detection was 0.06 ng/mL each for Der p 
1 and Der f 1, and mite group 2 allergens are detectable up to 
0.02 ng/mL.43 We investigated the weight (g) of collected dust of 
each sample and standardized the concentrations to nanogram 
allergen per gram of dust (ng/g). Spearman’s rho correlation of 
allergen concentration with altitude, temperature, fine dust, 
and humidity was calculated using SPSS software (SPSS Inc., 
Chicago, IL, USA, version 22.0). Comparing of means was done 
with the Mann-Whitney U Test for independent samples. The 
relationship of indoor environmental characteristics with the 
concentration of allergens was calculated using univariate 
ANOVA and the post hoc Bonferroni test. The limit of signifi-
cance was set to 0.05.
Environmental parameters
Particulate matter (PM-1, PM-2.5 and PM-10 in µg/m3), tem-
perature, and RH% were measured with a Grimm Model 1.108 
Portable Aerosol Spectrometer (Grimm, Aerosol Technik GmbH 
Co, Ainring, Germany). The spectrometer was positioned at a 
height of 50 cm in the middle of each room, and a ventilator 
was arranged for air circulation. The period of measurement 
covered about 5 minutes per room. The individual values were 
averaged arithmetically. 
In addition, the position of each building was determined via 
GPS, and data concerning indoor environmental parameters 
(number of windows, type of glazing, type of flooring, age of 
building, quantity of linens, type of heating, people per day/
night, floor number, number of beds, type and intensity of us-
age, cleaning method, and frequency) were collected and stored 
in an iPad® database system (Tap Zapp Software Inc., Calgary, 
Canada). 
RESULTS
Allergen concentrations and height
All allergens (Der p 1, Der f 1, and mite group 2) were detect-
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able in 100% of the 122 dust samples collected. The concentra-
tion of mite allergens showed high variations. Mite group 2 
ranged from 0.01 to 229.12 ng/g (arithmetic mean: 24.49±36.49 
ng/g). Der p 1 levels varied from 0.03 to 426.90 ng/g (arithmetic 
mean: 32.59±63.16 ng/g), and Der f 1 levels ranged from 0.08 
to 1,703.69 ng/g (arithmetic mean: 95.04±226.42 ng/g) (Fig. 1). 
Normal distribution tests failed. 
No correlation could be measured between concentrations of 
the allergens Der p 1 and mite group 2 with the altitude (Der p 
1: r=0.088, P=0.334; mite group 2: r=-0.098, P=0.285). Der f 1 
showed a weak negative correlation with the altitude (Der f 1: 
r=-0.319/P<0.001), which may have been due to a markedly 
higher concentration of Der f 1 in the altitude range below 1,500 
m compared to Der p 1 allergen levels (P=0.001). There was a 
huge percentage disparity of Der p 1 and Der f 1 allergens be-
low 1,500 m altitude (Fig. 2). Concentrations of Der p 1 and Der 
f 1 allergens did not differ in samples taken above 1,500 m a.s.l. 
(P=0.689).
No statistically significant difference could be found between 
allergen concentrations of samples taken above and below 
1,500 m a.s.l. of both Der p 1 (P=0.928) and mite group 2 aller-
gens (P=0.127) (Fig. 3). Only Der f 1 was reduced in higher alti-
tude (P<0.001).
In general, mattresses represent a superior biotope for HDM 
compared to floors. Consistently, allergen concentrations of 
samples collected from mattresses were significantly higher 
than those taken from the floors (Der p 1: P=0.001; Der f 1: 
P=0.005; mite group 2: P=0.017) reflecting a stoichiometric re-
lationship of ~ 2:1 (Fig. 4). 
One part of the samples (n=37) was taken from buildings that 
were only used 6 months a year, at an altitude of 1,750-2,600 m 
and fully frozen during winter. The other part (n=85) originat-
ed from buildings at altitudes of 420-1,650 m, which were occu-
pied all throughout the year. Despite the drastic differences in 
Fig. 1. Total number of allergens: Data shown as distribution of individual aller-
gen concentrations of Der p 1, Der f 1, and Mite group 2 with means (grey 
lines). n=122 each.
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Fig. 2. Percentage of allergen concentrations of Der p 1, Der f 1 and Mite group 
2 of the samples taken at 400-1,500 m a.s.l. (n=65) and 1,500-2,600 m a.s.l. 
(n=57). There are significant higher Der f 1 allergen levels compared to those 
of Der p 1 (P=0.001) below 1,500 m, but no concentration differences at higher 
altitude (P=0.689).
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Fig. 3. Allergen concentrations of Der p 1, Der f 1, and Mite group 2 of the sam-
ples taken above (n=57) and below 1,500 m a.s.l. (n=65). There are significant 
lower Der f 1 allergen levels at high altitude compared to allergen levels below 
1,500 m a.s.l. (P<0.001). For Der p 1 and Mite 2 allergens, no concentration dif-
ferences between high and low altitudes could be detected (Der p 1: P=0.928; 
Mite 2: P=0.127).
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Fig. 4. Comparison of allergen concentrations of the samples taken from floors 
(F) and mattresses (M) with standard deviations. Allergen concentrations of all 
3 HDM allergens were significantly higher in mattresses (Der p 1: P=0.001; 
Der f 1: P=0.005; Mite group 2: P=0.017).
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the living conditions for dust mites in these 2 groups, no signifi-
cant changes in allergen concentration could be detected for 
Der p 1 and mite group 2 allergens (Der p 1: P=0.832; mite 
group 2: P=0.672). Only Der f 1 allergens showed less concen-
trations in samples taken from buildings closed and unheated 
during the winter (Der f 1: P=0.005) (Fig. 5). 
Allergen concentrations, temperature, and humidity
Air temperature in different buildings ranged from 14.03°C to 
24.96°C (arithmetic mean: 20.55°C±2.7°C). There was a clear 
negative correlation of temperature to rising altitude (r=-0.537; 
P<0.001), but no relationship between temperature and the 
concentration of mite allergens could be measured (Der p 1: 
r=-0.133, P=0.201, Der f 1: r=0.027, P=0.799, mite group 2: r=  
-0.077, P=0.459). There was also a high variation in RH, rang-
ing from 21% to 56% (arithmetic mean: 44.05±8.95%), and RH 
also showed a clear negative correlation with altitude (r=-0.635; 
P<0.001). However, in contrast to previous studies, there was 
no correlation between allergen concentrations and RH (Der p 
1: r=-0.158; P=0.129; Der f 1: r=-0.047; P=0.652; mite group 2: 
r=-0.102; P=0.328) (Fig. 6).
Allergen concentrations, fine dust, and dwelling conditions
Fine dust PM10 ranged from 5.70 to 468.50 µg/m3 (arithmetic 
mean: 57.49±71.90 µg/m3), PM-2.5 from 1.18 to 56.37 µg/m3 
(arithmetic mean: 11.44±11.20 µg/m3), and PM-1 from 0.39 to 
47.28 µg/m3 (arithmetic mean: 7.51±8.60 µg/m3). Indoor fine 
dust PM values (n=111) showed no correlation with altitude or 
the weight of collected dust samples. A positive correlation was 
found for the weight of dust in the collected samples from floors 
and mattresses with concentration of mite allergens (Der p 1: 
r=0.359, P<0.001; Der f 1: r=0.398, P<0.001; Mite group 2: 
r=0.406, P<0.001). Concentrations of mite allergens also 
showed weak negative correlations with most of the measured 
PM (Table).
Interestingly, indoor environmental characteristics, such as 
the type of heating, number of windows and beds, type of glaz-
ing, application, quantity of users (day and night), subjective 
quantity of linens used in the room, age of building or type of 
ventilation, also showed no association with concentrations of 
mite allergens. Not even methods or frequencies of cleaning 
were related to levels of detected allergens. A insignificant dif-
ference could be found between different types of floors. Stone 
floors displayed the lowest allergen concentrations (arithmetic 
mean: Der p 1: 20.93 ng/g, Der f 1: 11.44 ng/g, mite group 2: 
10.86 ng/g), whereas vinyl floors showed the highest concen-
trations of Der p 1 and mite group 2 allergens (arithmetic mean 
Der p 1: 56.12 ng/g, mite group 2: 29.30 ng/g). The highest Der f 
1 allergen concentrations were found on laminate floors (arith-
metic mean Der f 1: 124.83 ng/g).
DISCUSSION 
The results of the present study, performed in alpine regions 
of Germany and Austria, clearly indicate that the concentration 
Table. Fine dust pollution correlated with the concentration of allergens
PM-10 (µg/m3) PM-2.5 (µg/m3) PM-1 (µg/m3)
Der p 1 (ng/g) r -0.246† -0.203* -0.162
P 0.009 0.032 0.090
Der f 1 (ng/g) r -0.107 -0.354† -0.420†
P 0.263 0.001 0.000
Mite 2 (ng/g) r -0.121 -0.304† -0.341†
P 0.206 0.001 0.000
*level of significance ≤5%; †+level of significance ≤1%.
Fig. 5. HDM allergen concentrations in different habitats. Means and standard 
deviation indicate allergen concentrations given in ng/g of dust of the samples 
from buildings used year-round (n=85) and from those used only half a year 
(n=37).
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Fig. 6. Relative air humidity (RH) to allergen concentration. The linear regres-
sion indicates no correlation between Der p 1, Der f 1, and Mite group 2 aller-
gens with relative air humidity.
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of the HDM allergens Der p 1 and mite group 2 does not signifi-
cantly decrease at high altitude. Moreover, no correlation be-
tween altitude, RH, and HDM allergen concentrations could be 
found. Even in mountain huts at high altitude that were not 
used in winter and thus were fully frozen at that time, HDM 
concentrations did not differ from buildings located at lower al-
titudes which were occupied throughout the year. Similarly, 
dwelling conditions did not significantly alter the allergen load. 
Only Dermatophagoides farinae shows a weak negative but sig-
nificant correlation with rising altitudes. Based on this fact, we 
assume a higher sensitivity of the American HDM and poorer 
ability to adapt to changes. The dry and cold air at high altitude 
may also affect the stability of Der f 1 allergen in comparison 
with Der p 1 and mite group 2 allergens.
As one would expect, outdoor air pollution at high altitude is 
generally lower; however, indoor fine dust pollution did not sig-
nificantly change with altitude. The difference in allergen con-
centration in the disturbed air and the settled dust could be at-
tributed to the feature of fine dust, binding to allergens on its 
surface. The higher the particulate matter, the more allergens 
are hovering in the disturbed air, compared to allergen levels 
determined in the settled dust on floors or mattresses. This 
might have a big impact on the health-related quality of life of 
HDM allergic patients in rooms with high fine dust pollution.
Our data are in line with publications questioning the para-
digm “the higher altitude, the lower the allergen concentra-
tions”,24-27 which was primarily based on the assumption that a 
hostile environment to mites accompanied by a reduction in 
the number of mites (or elimination of mites during winter in 
frozen buildings) may eliminate the allergens. This biological 
view may be correct for the mite itself, but its proteins can be 
stable over a long period of time. Obviously, this is the case with 
HDM allergens, and high HDM allergen concentrations mea-
sured in chalets at high altitude that are frozen for several 
months a year favor this interpretation. We postulate, that after 
mites die away, the allergen concentration remains high for a 
prolonged period, and freezing may even prolong the amount 
of intact allergens. It has already been shown that mite aller-
gens are chemically stable for up to four years.44 During warmer 
periods, small populations of mites regenerate, and as people 
return, more mites are imported, and they deposit “fresh” aller-
gen again. It would be interesting, especially in these specific 
chalets or mountain huts, to measure the fluctuation in the 
mite population and the allergen concentration. Due to the 
mechanism we postulate, the fluctuation in the latter should be 
low, and in sum the allergen load would be as high as at lower 
altitudes.
Nevertheless, there is evidence of a salutary effect that accom-
panies a stay in high-altitude regions for people allergic to 
HDM, which has been demonstrated in both pediatric45,46 and 
adult patients with allergic and intrinsic, moderate and severe 
asthma.47 Interestingly, patients with intrinsic asthma also show 
a reduction in airway inflammation. 
Taken together, it is clearly indicated that the mitigating effect 
of high-altitude climate therapy for allergic asthma can no lon-
ger be ascribed to a reduction in HDM allergen in the environ-
ment. Other mechanisms remain to be responsible for the ben-
eficial effects. Recent studies address several factors, such as re-
duced humidity, low endotoxin load, decreased exposure to 
fungal spores, pollen, and air pollution, which may contribute 
to the positive influence of high climate therapy on allergic pa-
tients and asthmatics.45,47,48 Furthermore, higher air fluidity and 
lower oxygen concentration at high altitude reduce respiratory 
resistance and aid in breathing. In addition, increased UV-light 
exposure can modulate the immune system and holiday-mak-
ers visiting high-altitude regions experience a relief from stress 
during their stay. Also these parameters may have an influence 
on allergy symptoms and asthma control, comparable to me-
dicinal immunotherapies.48,49
The contradictory data concerning the occurrence of HDM, 
based on altitude and RH, may be partially explained by chang-
es in building construction (modern insulation, heating, and 
glazing) and climate changes (global warming) since the 
1970s.3,50 However, our data also contradict the widespread as-
sumption that improved isolation of buildings and more fre-
quent heating of rooms, in comparison to previous decades, 
leads to a higher allergen concentration at high altitude. Again, 
the HDM concentration in buildings completely frozen during 
several winter months provides the strongest argument against 
this postulate. 
Similarly, postulations from older papers have to be critically 
addressed, e.g. it has been reported that HDMs need a RH of 
70%-80% to develop, and stop growing and die at a RH of 60% 
and lower.19,33 We measured RH in most of the rooms in which 
the 122 dust samples were collected for this study. Though the 
relative air humidity was below 60% in all rooms (n=53), all the 
samples contained HDM allergens. Whether humidity is not the 
only and/or major controlling factor for the development and 
growth of mite populations, or there is a higher RH of the micro-
environment of mites, cannot be determined by this study. 
Another reason for the differing results in literature may be im-
proved immuno-chemical techniques, which now allow for the 
targeted detection of very low allergen concentrations in dust 
samples.
CONCLUSIONS
We provide evidence that HDM allergen levels are not signifi-
cantly lower in mountainous areas of the alpine region of Ger-
many and Austria. The data indicate that recovery of asthmat-
ics and allergic sufferers during a stay in a high-altitude region 
is not the result of lacking allergen (allergen avoidance), as has 
been postulated for several decades. Hitherto unknown mech-
anisms, possibly triggered by stationary effects or climatic con-
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ditions, seem to be responsible for mitigating the allergic im-
mune response, at least its effector phase. 
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